<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0022">
 <label>22</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <string-name>
    <surname>Ben-Nun</surname>
    <given-names>D</given-names>
   </string-name>, 
   <string-name>
    <surname>Buja</surname>
    <given-names>LM</given-names>
   </string-name>, 
   <string-name>
    <surname>Fuentes</surname>
    <given-names>F.</given-names>
   </string-name>
  </person-group>
  <article-title>Prevention of heart failure with preserved ejection fraction (HFpEF): reexamining microRNA-21 inhibition in the era of oligonucleotide-based therapeutics</article-title>. 
  <source>Cardiovasc Pathol</source>. 
  <year>2020</year>;
  <volume>49</volume>:
  <fpage>107243</fpage>.
  <pub-id pub-id-type="pmid">32629211</pub-id>
 </mixed-citation>
</ref>
